Navigation Links
Federal bioenergy lab will give Wisconsin a chance to shine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Federal bioenergy lab will give Wisconsin chance shine

(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
... March 10 AutoGenomics, a leader in,developing au...ay that it,will be among the leading healthcare an...nnual Cowen Health Care Conference that will be he...Massachusetts. Fareed Kureshy,President and Chief ...company, its automated molecular testing platform ...
...sed on data previously reported, communicated in l...DGEWATER, N.J., March 7 Ortho Biotech Products, L...CRIT(R) (Epoetin alfa),following guidance from the... labeling for all drugs within the erythropoiesis-...the label were based on an unplanned interim analy...
...E, Ind. - The National Nuclear Security Administra...nt for a research center at Purdue University,s Di...ommercial and defense applications, Purdue officia...focus on the behavior and reliability of miniature...ence chosen by the NNSA. , About 35 researchers a...
Other Biology Technology:Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 5Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 6Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 7Purdue leads center to simulate behavior of micro-electromechanical systems 2Purdue leads center to simulate behavior of micro-electromechanical systems 3Purdue leads center to simulate behavior of micro-electromechanical systems 4
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
Breaking Biology News(10 mins):Stem cells battle for space 2Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 1Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 2Abbott to Acquire Nutrition Businesses Expanding Presence in India 52926 3Nexicon Technology to Protect Healthcare Industry 52924 1Nexicon Technology to Protect Healthcare Industry 52924 2Nexicon Technology to Protect Healthcare Industry 52924 3Nexicon Technology to Protect Healthcare Industry 52924 4Nexicon Technology to Protect Healthcare Industry 52924 5Must Haves for Your Summer Vacation Bag 52922 1Must Haves for Your Summer Vacation Bag 52922 2Must Haves for Your Summer Vacation Bag 52922 3
...(April 13, 2008, 1:00 p.m. ET) Research published ...ific inhibitors of a cell death pathway, termed ne...rotein that can direct cells into necrosis. Induce... form of necrotic death can result in tissue damag...he findings present a novel avenue for drug develo...
... to significantly boost our understanding of the f...Anglia (UEA) and the Lowestoft-based Centre for En... are launching a new strategic alliance. , The al...een the two institutions and establish exciting ne... climate change on the marine environment will inf...
... being presented today (11 April) at the UK Nation...nburgh could offer hope that bone stem cells may b...s one of the main symptoms of osteoarthritis. , S...identified stem cells within articular cartilage o... in the body like full stem cells, has the ability...
Other Biology News:Stopping unwanted cell death: Implications for drug discovery 2Stopping unwanted cell death: Implications for drug discovery 3New UEA-Cefas alliance launched 2Stem cells offer cartilage repair hope for arthritis sufferers 2
PCASMC (P350-05) from European Collection of Cell Cultures (ECACC)
Rabbit Anti-alpha-N-Catenin Polyclonal Antibody, Unconjugated from Cell Signaling Technology
BioDoc-It System from UVP
AC1 Auto System, OptiChemi™ Camera from UVP
Biology Products: